Previous close | 4.4100 |
Open | 4.5000 |
Bid | 4.3200 x 1300 |
Ask | 4.3300 x 1000 |
Day's range | 4.1800 - 4.5450 |
52-week range | 1.4200 - 10.8800 |
Volume | |
Avg. volume | 6,127,903 |
Market cap | 227.66M |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | -10.9700 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.00 |
Q1 2024 Emergent BioSolutions Inc Earnings Call
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript May 1, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone. I’m […]
Emergent BioSolutions Inc (EBS) showcases robust revenue growth and operational efficiency in the first quarter of 2024.